Skip to content

Clinical trials

Neoplasm Metastasis trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: Denmark Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20063
20075
20084
20092
20103
20117
20123
20133
20146
20153
20164
20174
20182
20195
20205
20218
20225
20231
20244
20257

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Recruiting14
Active, not recruiting13
Terminated13
Unknown status7
Withdrawn4
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Eli Lilly and Company6
AbbVie4
Novartis Pharmaceuticals4
Rigshospitalet, Denmark4
Sanofi4
Copenhagen University Hospital at Herlev3
European Organisation for Research and Treatment of Cancer - EORTC3
Institut de Recherches Internationales Servier3
Odense University Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis87
Colorectal Neoplasms14
Neoplasms14
Breast Neoplasms10
Carcinoma, Non-Small-Cell Lung10
Prostatic Neoplasms7
Carcinoma, Renal Cell4
Carcinoma, Transitional Cell4
Lung Neoplasms4
Pancreatic Neoplasms4

Trials

Showing 26 to 50 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.